BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4209835)

  • 1. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
    Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
    Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential analysis of cyclocytidine, 1-beta-D-arabinofuranosylcytosine, and 1-beta-D-arabinofuranosyluracil by ultraviolet spectophotometry.
    Furner RL; Gaston RW; Strobel JD; el-Dareer S; Mellett LB
    J Natl Cancer Inst; 1974 May; 52(5):1521-8. PubMed ID: 4208713
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine.
    Dexter DL; Wolberg WH; Ansfield FJ; Helson L; Heidelberger C
    Cancer Res; 1972 Feb; 32(2):247-53. PubMed ID: 4333494
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic fate of O2,2'-cyclocytidine.
    Ho DH
    Drug Metab Dispos; 1973; 1(6):752-5. PubMed ID: 4156296
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance of cyclocytidine to cytidine deaminase.
    Hoshi A; Iigo M; Saneyoshi M; Kuretani K
    Chem Pharm Bull (Tokyo); 1973 Jul; 21(7):1535-8. PubMed ID: 4731230
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the uptake of tubeidin (7-deazaadenosine) by blood cells and its distribution in whole animals.
    Smith CG; Reinekelm ; Burch MR; Shefner AM; Muirhead EE
    Cancer Res; 1970 Jan; 30(1):69-75. PubMed ID: 5441082
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children.
    Finklestein JZ; Scher J; Karon M
    Cancer Chemother Rep; 1970 Feb; 54(1):35-9. PubMed ID: 5538163
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
    Hayes A; Cooper RG
    J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys.
    El Dareer SM; White VM; Chen FP; Mellet LB; Hill DL
    Cancer Treat Rep; 1977 Oct; 61(7):1269-77. PubMed ID: 412588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 6-amino-5-(N-methylformylamino)-1,3-dimethyluracil, one of the primary metabolites of caffeine, in the rat.
    Bonati M; Bortolotti A; Jiritano L; Latini R; Garattini S
    Drug Metab Dispos; 1983; 11(5):509-11. PubMed ID: 6138240
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic studies of cyclocytidine and arabinosylcytosine in dogs.
    Ho DH; Carter CJ; Loo TL; Abbott RL; McBride CM
    Drug Metab Dispos; 1975; 3(4):309-13. PubMed ID: 240662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects.
    Runkel R; Chaplin M; Boost G; Segre E; Forchielli E
    J Pharm Sci; 1972 May; 61(5):703-8. PubMed ID: 4624708
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
    Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
    Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of diazoxide in man and experimental animals.
    Pruitt AW; Faraj BA; Dayton PG
    J Pharmacol Exp Ther; 1974 Jan; 188(1):248-56. PubMed ID: 4203373
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution and excretion of 14C-cyclocytidine in experimental animals.
    El Dareer SM; White VM; Tillery K; Chen FP; Mellett LB; Hill DL
    Cancer Treat Rep; 1977 Aug; 61(5):805-14. PubMed ID: 70271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of pramiverine in rats, dogs, and monkeys (author's transl)].
    Steiner K; Diekmann HW; Garbe A; Nowak H
    Arzneimittelforschung; 1976 Apr; 26(4b):717-21. PubMed ID: 821494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.